Nerisopam
![]() | |
Clinical data | |
---|---|
ATC code | none |
Identifiers | |
| |
CAS Number |
102771-12-0 ![]() |
PubChem (CID) | 65875 |
ChemSpider |
59284 ![]() |
UNII |
18Q4O339AG ![]() |
ChEMBL |
CHEMBL2104732 ![]() |
Chemical and physical data | |
Formula | C18H19N3O2 |
Molar mass | 309.36 |
3D model (Jmol) | Interactive image |
| |
| |
![]() ![]() |
Nerisopam (GYKI-52322) is a drug which is a 2,3-benzodiazepine derivative, related to tofisopam. It has potent anxiolytic and neuroleptic effects in animal studies.[1][2][3]
See also
References
- ↑ Horváth K, Andrási F, Berzsenyi P, Pátfalusi M, Patthy M, Szabó G, Sebestyén L, Bagdy E, Körösi J, Botka P. A new psychoactive 5H-2,3-benzodiazepine with a unique spectrum of activity. Arzneimittelforschung. 1989 Aug;39(8):894-9.
- ↑ Horváth K, Andrási F, Botka P, Hámori T. Anxiolytic profile of girisopam and GYKI 52,322 (EGIS 6775). Comparison with chlordiazepoxide and buspirone. Acta Physiologica Hungarica. 1992;79(2):153-61.
- ↑ Palkovits M, Baffi JS, Berzsenyi P, Horváth EJ. Anxiolytic homophthalazines increase Fos-like immunoreactivity in selected brain areas of the rat. European Journal of Pharmacology. 1997 Jul 16;331(1):53-63.
This article is issued from Wikipedia - version of the 9/29/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.